Ilika plc Contracted Revenue Grows – AGM Statement

Ilika plc

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology and materials innovation, will hold its Annual General Meeting at 2pm today at the offices of Eversheds LLP, One Wood Street, London, EC2V 7WS. Ahead of the formal proceedings Graeme Purdy, Chief Executive of Ilika, will provide the following update to shareholders:

“We are pleased to report that the first quarter of the year has traded in-line with the Board’s expectations and contracted revenue to date for our current financial year has grown to £2.0m.

“Since the announcement of our final results in July, the Company has made good progress towards the goals set out in the StereaxTM development roadmap. Our marketing activities have resulted in an increase in the number of customer disclosure agreements to around 50, including those covering the transfer of StereaxTM products for evaluation, bringing the Company ever closer to licensing agreements.

“The Board remains focused on the development and licensing of Ilika’s solid-state battery technology, investing in the StereaxTM roadmap, finalising manufacturing partnerships and ultimately securing licensing agreements for our StereaxTM technology.”

Ilika plc presentation

After the formal business of the AGM has come to an end, Graeme Purdy, will provide a short presentation to investors with an overview of progress and strategy. No new material will be disclosed in the presentation and it will be made available on the website today.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Ilika to present at Yellowstone Advisory Private Investor evening

Ilika announces that CEO Graeme Purdy and CFO Jason Stewart will present at the Yellowstone Advisory Private Investor evening on 25 February 2026 at Hudson Sandler, London.

10 Top ESG stocks on AIM 2026

These ten AIM-quoted ESG stocks offer investors exposure to companies where commercial progress and responsible business practices go hand in hand.

Ilika reports on-track progress across Stereax and Goliath in H1 2025/26

Ilika reports unaudited half-year results to 31 October 2025, highlighting on-schedule delivery of key commercial milestones across its Stereax medical battery and Goliath EV battery programmes, alongside continued customer validation, pilot-line commissioning, and £4.2m fundraising to support its roadmap.

Ilika secures first commercial Stereax electrode order from Cirtec Medical

Ilika has received its first revenue-generating purchase order from Cirtec Medical for the supply of Stereax electrodes, marking the transition of their partnership into commercial production.

Ilika plc 2025 Review, Stereax Commercial Shipments, Goliath Scale-Up and Funding Progress

Take a look back at Ilika’s 2025 progress, as the company moved from laboratory validation to manufacturing, delivering key Stereax and Goliath solid-state battery milestones.

Ilika ships first Stereax M300 prototypes

Ilika has begun shipping prototype Stereax M300 solid state batteries to customers, marking a key commercial milestone for the company.

Search

Search